Table 2 Genetic characteristics of 20 HLDs patients

From: Genetic analysis of 20 patients with hypomyelinating leukodystrophy by trio-based whole-exome sequencing

Pt

Gene

Transcript

CDS

Protein

Or

N/R

GE

CA

SI

Po

MT

Co

MC

PR

1

TUBB4A

NM_006087.3

c.1164 G > T

p.(M388I)

d

N

3.4

23.8

D

D

D

D

N

D

2

TUBB4A

NM_006087.3

c.1062 C > G

p.(C354W)

d

R

0.6

25.5

D

D

D

D

D

D

3

TUBB4A

NM_006087.3

c.1062 C > G

p.(C354W)

d

R

0.6

25.5

D

D

D

D

D

D

4

POLR3A

NM_007055.3

c.661_662insCCT

p.(P220_L221insS)

m

N

5.1

   

c.1770 + 5 G > C

p.(P591Vfs*28)

p

N

4.8

7.2

-–

5

POLR1C

NM_001318876.1

c.322 C > T

p.(H108Y)

p

N

5.6

29.8

D

D

D

D

D

D

   

c.883_885delAAG

p.(K295del)

m

R

4.9

14.6

6

POLR1C

NM_001318876.1

c.326 G > A

p.(R109H)

p

R

4.8

34.0

D

D

D

D

D

D

   

c.901 C > T

p.(R301W)

m

N

4.9

35.0

D

D

D

D

D

D

7

SOX10

NM_006941.3

c.227 T > A

p.(V76D)

d

N

4.4

27.6

D

D

D

D

D

D

8

TMEM106B

NM_001134232.1

c.754 G > A

p.(D252N)

d

#

5.4

32.0

D

D

D

D

D

D

9

DEGS1

NM_001321541.1

c.110 T > C

p.(M37T)

p

#

5.5

24.6

D

D

D

D

D

D

   

c.770 G > A

p.(W257*)

m

#

5.9

43.0

D

10

TMEM63A

NM_014698.2

c.1385 T > A

p.(I462N)

d

#

5.1

31.0

D

D

D

D

D

D

11

TMEM63A

NM_014698.2

c.503 G > A

p.(G168E)

d

#

5.9

26.9

D

D

D

D

D

D

  1. Pt patient, Or origin, m maternal, p paternal, d de novo, N novel, R reported, GE GERP + + RS, CA CADD, SI SIFT, Po PolyPhen, MT mutation taster, Co Condel, MC M-CAP, PR PROVEAN, D probably damaging in polyphen or deleterious in other software, N neutral, # patients with these variants have been reported in our previous paper